Literature DB >> 28154908

Mild asymptomatic intrahepatic biliary dilation after cholecystectomy, a common incidental variant.

Christopher J Atkinson1, Christopher J Lisanti2,3, Ryan B Schwope1,4, Daniel Ramsey1, Timothy Dinh1, Allyson Cochet5, Michael J Reiter6.   

Abstract

OBJECTIVE: The purpose of this study is to evaluate the prevalence of intra- and extrahepatic ductal dilatation in asymptomatic individuals after cholecystectomy. METHODS AND MATERIALS: This IRB-approved retrospective cohort study evaluated the prevalence of intra- and extrahepatic biliary dilation in 77 consecutive post cholecystectomy patients who had CT obtained in the portal venous phase. These were then compared to age and sex matched control patients. Two radiologists in consensus blinded to surgical history evaluated the intrahepatic ducts qualitatively for dilatation. A single radiologist using the best of three orthogonal planes measured the extrahepatic ducts. Extrahepatic ducts were considered dilated if >7 mm plus 1 mm/decade after 60 years. T tests and chi-squared tests were performed.
RESULTS: Cholecystectomy patient duct patterns: normal ducts 26% (20/77); intra- and extrahepatic dilation 31.2% (24/77); intrahepatic dilation only 18.2% (14/77); extrahepatic dilation only 24.7% (19/77). Control patient duct patterns: normal ducts 88.3% (68/77); intra- and extrahepatic dilation 2.6% (2/77); intrahepatic dilation only 2.6% (2/77); extrahepatic dilation only 6.5% (5/77). All intrahepatic ductal dilatation was mild. Total intrahepatic dilation: 49.4% (cholecystectomy); 5.2% (control patients). The relative risk of intrahepatic ductal dilation in cholecystectomy patients was 9.5:1. Increased prevalence of intra- and extrahepatic dilation in cholecystectomy patients was statistically significant (p < 0.0001). Average extrahepatic duct was 7.8 mm (cholecystectomy) and 5.3 mm (control patients) (p < 0.001).
CONCLUSION: Mild intrahepatic biliary dilation in the setting of cholecystectomy is very common, and if not associated with clinical or biochemical evidence of obstruction is likely of no clinical significance.

Entities:  

Keywords:  Biliary; Cholecystectomy; Dilatation; Intrahepatic

Mesh:

Substances:

Year:  2017        PMID: 28154908     DOI: 10.1007/s00261-016-1017-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  1 in total

1.  Successful liver-directed gene delivery by ERCP-guided hydrodynamic injection (with videos).

Authors:  Vivek Kumbhari; Ling Li; Klaus Piontek; Masaharu Ishida; Rongdang Fu; Bassem Khalil; Caroline M Garrett; Eleni Liapi; Anthony N Kalloo; Florin M Selaru
Journal:  Gastrointest Endosc       Date:  2018-07-03       Impact factor: 9.427

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.